Skip to content

Quantitative analysis of hippotherapy in patients with walking disabilities

Quantitative analysis of hippotherapy in patients with walking disabilities - Evaluation of hippotherapy using quantitative indicators

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000022986
Enrollment
100
Registered
2016-07-02
Start date
2013-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients presented with walking disabilities due to cerebral palsy, hydrocephalus (post-treatment), and stroke.

Interventions

Hippotherapy (30min once weekly) Control group without hippotherapy (e.g., recreation, non-therapeutic intervention) or age-matched normal database.

Sponsors

Holistic Betterment and Wellness Through Riding PIROUETTE, Japan
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Children and adolescents with cerebral palsy in the Kanto region of Japan were recruited by contacting the schools that cater for them with appropriate physiotherapy services, as well as via adjacent hospital/clinics.

Exclusion criteria

Exclusion criteria: Exclusion criteria included if they had 1) previous participation in hippotherapy, 2) history of fracture or epilepsy within 8 weeks of enrolment, and 3) cognitive or physical impairment sufficiently severe that would hinder study protocol. In addition, participants were excluded if they received medication or orthopedic surgery (e.g., botulinum toxin injection and selective dorsal rhizotomy) for treating tight muscles and spasticity related to CP during the study or within 3 months of the enrollment.

Design outcomes

Primary

MeasureTime frame
Short- and long-term improvement of hippothray assessed by Gross Motor Function Measure (GMFM).Temporospatial parameters of gait and balance abilities using a tri-axial motion recorder analysis for a 5-m or 10-m walikng test, score for dimensions D (standing) and E (walking, running, jumping) of the GMFM. Comparison was performed with control (recreation) or age-matched normal database subjects.

Secondary

MeasureTime frame
WHOQOL-BREF (Japanese version), CPQOL-child/-caregiver.

Countries

Japan

Contacts

Public ContactTatsushi Mutoh

Institute of Development, Aging and Cancer, Tohoku University Department of Nuclear Medicine and Radiology

tmutoh@tohoku.ac.jp022-717-8559

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026